GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $469,000 | +4.9% | 10,764 | +4.8% | 0.16% | +25.0% |
| Q1 2022 | $447,000 | -0.9% | 10,272 | +0.4% | 0.12% | +5.1% |
| Q4 2021 | $451,000 | +15.6% | 10,230 | +4.5% | 0.12% | -21.9% |
| Q2 2021 | $390,000 | +12.1% | 9,790 | +0.4% | 0.15% | +58.9% |
| Q1 2021 | $348,000 | -3.1% | 9,748 | +0.0% | 0.10% | -6.9% |
| Q4 2020 | $359,000 | -1.1% | 9,744 | +0.9% | 0.10% | -15.7% |
| Q3 2020 | $363,000 | -10.6% | 9,653 | -3.1% | 0.12% | -22.9% |
| Q2 2020 | $406,000 | +2.0% | 9,959 | -5.3% | 0.16% | -15.1% |
| Q1 2020 | $398,000 | -24.5% | 10,516 | -6.2% | 0.18% | +1.1% |
| Q4 2019 | $527,000 | +7.6% | 11,207 | -2.4% | 0.18% | +11.6% |
| Q3 2019 | $490,000 | +7.0% | 11,478 | +0.3% | 0.16% | -3.0% |
| Q2 2019 | $458,000 | -4.0% | 11,447 | +0.3% | 0.17% | -7.1% |
| Q1 2019 | $477,000 | +9.7% | 11,410 | +0.3% | 0.18% | -24.2% |
| Q4 2018 | $435,000 | – | 11,378 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |